Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical. J Clin Immunol. 2020;40(1):66–81.
Article PubMed PubMed Central Google Scholar
Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;40:24–64.
Mayor P, Eng K, Singel K, Abrams S, Odunsi K, Moysich KB, et al. Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry. J Allergy Clin Immunol. 2018;141(3):1028–35.
Corthay A. Does the immune system naturally protect against cancer? Front Immunol. 2014;197(5).
Mortaz E, Tabarsi P, Mansouri D, Khosravi A, Garssen J, Velayati A, et al. Cancers related to immunodeficiencies: update and perspectives. Front Immunol. 2016;7:365.
Article PubMed PubMed Central Google Scholar
Ward JP, Gubin MM, Schreiber RD. The role of neoantigens in naturally occurring and therapeutically induced immune responses to cancer. Adv Immunol. 2016;130:25–74.
CAS PubMed PubMed Central Google Scholar
Majhail NS. Secondary cancers following allogeneic hematopoietic cell transplantation in adults. Br J Haematol. 2011;154:301–10.
Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, et al. The landscape of genomic alterations across childhood cancers. Nature. 2018;555:321–7.
Schutte P, Moricke A, Zimmermann M, Bleckmann K, Reismuller B, Attarbaschi A, et al. Preexisting conditions in pediatric ALL patients: spectrum, frequency and clinical impact. Eur J Med Genet. 2016;59(3):143–51.
Article CAS PubMed Google Scholar
Zhang J, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. 2015;373:2336–46.
Article CAS PubMed PubMed Central Google Scholar
Kratz CP, Stanulla M, Cavé H. Genetic predisposition to acute lymphoblastic leukemia: overview on behalf of the I-BFM ALL host genetic variation working group. EJMG. 2016;59:111–5.
Béziat V, Jouanguy E. Human inborn errors of immunity to oncogenic viruses. Curr Opin Immunol. 2021;72:277–85.
Article PubMed PubMed Central Google Scholar
Kindler O, Quehenberger F, Benesch M, Seidel MG. The iceberg map ofgermline mutations in childhood cancer: Focus on primary immunodeficiencies. Curr Opin Pediatr. 2018;30:855–63.
Article CAS PubMed Google Scholar
Jonkman-Berk BM, van den Berg JM, ten Berge IJM, Bredius RGM, Driessen GJ, Dalm VASH, et al. Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy. Clin Immunol. 2015;156:154–62.
Article CAS PubMed Google Scholar
Gathmann B, Mahlaoui N, Gerard L, Oksenhendler E, Warnatz K, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116–26.
Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol. 2000;120(2):225.
Article CAS PubMed PubMed Central Google Scholar
Tanyildiz HG, Dincaslan H, Yavuz G, Unal E, Ikinciogullari A, Dogu F, et al. Lymphoma secondary to congenital and acquired immunodeficiency syndromes at a Turkish pediatric oncology center. J Clin Immunol. 2016;36(7):667–76.
Article CAS PubMed Google Scholar
Seidemann K, Henze G, Beck JD, et al. Non-Hodgkin’s lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Ann Oncol. 2000;11(Suppl. 1):141–5.
Castilla EE, Gómez MA, Lopez-Camelo JS, Paz JE. Frequency of first-cousin marriages from civil marriage certificates in Argentina. Hum Biol. 1991;63(2):203–10.
Registro Oncopediátrico Hospitalario Argentino (ROHA) 2018 of the Instituto Nacional del Cáncer (INC): https://www.argentina.gob.ar/salud/instituto-nacional-del-cancer/institucional/roha. Accessed 2018.
Sheu MS, Hawryluk EB, Guo D, London WB, Huang JT, et al. Voriconazole phototoxicity in children: a retrospective review. J Am Acad Dermatol. 2015;72(2):214–20.
Bomken S, Werff Ten Bosch JVD, Attarbaschi A, et al. Current understanding and future research priorities in malignancy associated with inborn errors of immunity and DNA repair disorders: the perspective of an interdisciplinary working group. Front Immunol. 2018;9:2912.
Article CAS PubMed PubMed Central Google Scholar
Duan L, Grunebaum E. Hematological malignancies associated with primary immunodeficiency disorders. Clin Immunol. 2018;194:46–59.
Article CAS PubMed Google Scholar
Vajdic CM, Mao L, van Leeuwen MT, Kirkpatrick P, Grulich AE, Riminton S. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood. 2010;116:1228–34.
Article CAS PubMed Google Scholar
Chrzanowska KH, Gregorek H, Dembowska-Bagińska B, Kalina MA, Digweed M. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis. 2012;7:13.
Article PubMed PubMed Central Google Scholar
https://lasidregistry.org/, last accessed on February 10th, 2024.
Satgé D. A tumor profile in primary immune deficiencies challenges the cancer immune surveillance concept. Front Immunol. 2018;9:1149.
Article PubMed PubMed Central Google Scholar
Hauck F, Voss R, Urban C, Seidel MG. Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders. J Allergy Clin Immunol. 2018;141(1):59–68.
Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois d’Enghien C, Brousse N, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33:202-8.30.
Fekrvand S, Yazdani R, Abolhassani H, Ghaffari J, Aghamohammadi A. The first purine nucleoside phosphorylase deficiency patient resembling IgA deficiency and a review of the literature. Immunol Invest. 2019;48(4):410–30.
Article CAS PubMed Google Scholar
Kiykim A, Simsek I, Kiykim E, et al. Two patients with novel missense mutation in the purine nucleoside phosphorylase gene without serious or recurrent infections. Clin Exp Neuroimmunol. 2016;7(1):79–82.
Derpoorter C, Bordon V, Laureys G, Haerynck F, Lammens T. Genes at the Crossroad of Primary Immunodeficiencies and Cancer. Front Immunol. 2018;9:2544.
Article PubMed PubMed Central Google Scholar
Tangye SG. Genetic susceptibility to EBV infection: insights from inborn errors of immunity. Hum Genet. 2020;139(6–7):885–901. https://doi.org/10.1007/s00439-020-02145-3.
Latour S, Fischer A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases. Immunol Rev. 2019;291(1):174–89. https://doi.org/10.1111/imr.12791.
Article CAS PubMed Google Scholar
Tiri A, Masetti R, Conti F, Tignanelli A, Turrini E, Bertolini P, Esposito S, Pession A. Inborn Errors of Immunity and Cancer. Biology (Basel). 2021;10(4):313.
Kuehn HS, Boast B, Rosenzweig SD. Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency. Clin Exp Immunol. 2023;212(2):129–36.
Baleydier F, Bernard F, Ansari M. The possibilities of immunotherapy for children with primary immunodeficiencies associated with cancers. Biomolecules. 2020;10(8):E1112.
留言 (0)